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A series of strained alkynes were prepared from 2,2’-dihydroxy-
biaryls. Several were characterised by X-ray crystallography,
revealing strained C(sp)–C(sp)–C(sp3) bond angles in the range
of 163–167°. Their cycloadditions with azides proceed without a
catalyst. Functionalised versions of these reagents have potential
applications to materials synthesis and bioconjugations.
Azides react with terminal alkynes to form a triazole in what is
commonly referred to as a ‘click’ reaction.1–6 Reactions of this
type proceed under mild conditions, in high conversion and
their biorthogonal nature allows them to be used to attach
functional molecules (e.g. dyes, fluorescent groups, drugs etc.)
to biomolecules, and to create antibody/drug conjugates
(ADCs) for therapeutic use.7–9 The undesirable requirement for
the use of a copper catalyst can be eliminated through the use
of reactive strained alkynes in ‘Strain-Activated Alkyne Azide
Cycloaddition’.10 Examples of recently-reported strained
alkynes are illustrated in Fig. 1.11–21
The majority of reported strained alkynes contain 8-mem-
bered rings, however there are some examples of 9-membered
ring reagents20 such as the 2-amidobenzene sulphonamide
cyclononane21 and even a 19-membered crown ether,22 both
illustrated in Fig. 1. Thiacycloakyne and dibenzoselenacyclo-
heptynes have also been reported.23
Strained alkynes have also been used to conjugate func-
tional polymers, for example to combine24a contrasting chains
and to form crosslinks in the formation of hydrogels.24b They
have also been used to create modified pharmaceutical
agents.25 Of the reported strained reagents, DIBO, DIBAC and
BCN, due to their high reactivity, have been particularly widely
adopted for bioconjugation reactions.11 In this paper, we
describe the synthesis and applications of a class of strained
alkyne which can be prepared through a short and facile syn-
thetic sequence from readily available and inexpensive starting
materials.
Following a single precedent in the literature,26a we investi-
gated the reaction of biaryl diols with 1,4-ditosyl-but-2-yne,
which resulted in the formation of cyclic alkynes 1–4 (Fig. 2). A
literature search revealed just two other reports of this hetero-
cyclic structure, both binaphthyl-derived,26b,c whilst their reac-
tions with azides have not been reported. The 2,2′-biphenols
and their strained-alkyne derivatives are racemic, however
compound 2 was prepared as a single enantiomer derived
from (R)-BINOL. Compounds 2–4 27,28 were characterised by
X-ray crystallography (Fig. 3) which served to confirm the
strained nature of the triple bonds in each product. The sp
angles at the triple bonds (C(sp)–C(sp)–C(sp3)) in 3 and 4 were
ca. 166–167°, however, due to the presence of three crystallo-
Fig. 1 Examples of strained alkynes which react with azides without
the requirement for a copper catalyst. R represents a point of attach-
ment to either a biomolecule or other functional group.
Fig. 2 Strained alkynes 1–4 derived from biaryl and binapthyl diols.
†Electronic supplementary information (ESI) available: Full experimental
details, NMR spectra, X-ray crystallographic structures and kinetic data (pdf ).
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graphically independent molecules in the unit cell of 2, the sp
bond angles in this molecule ranged from 166.9–163.0° with
an average of ca. 165°. The high aryl/aryl torsion angles (Fig. 3)
reflect the wide spacing required to accommodate the linear
butyne component in the ring. This angle increased to 112.5°
in the dibromo 3 and 122.1° in the tetrabromo compound 4.
The strain in the alkyne is reflected in the reactivity of 1–4
towards benzyl azide and arylazides (Scheme 1), which
resulted in formation of cycloaddition products 5–8 in high
yields, at room temperature, and without the need for a metal
catalyst. The X-ray crystallographic structure of cycloadduct 5a
(Fig. 4) revealed a low torsion angle between the aromatic
rings of just 43°, reflecting the greater flexibility of the
triazolyldimethylene bridge.
Conversions to cycloadducts were typically ca. 90% or
higher at 40 °C within 24 h in several cases, however the reac-
tions could be run for several days without substrate decompo-
sition, to generate products in high yield even at the lower
temperature. The cycloaddition of a nitrile oxide (generated
in situ from the chloride precursor)29 to give adduct 9, was also
completed (Scheme 1).
The second-order rate constants for a number of the reac-
tions were determined (Table 1, ESI†). The reactions of the
unsubstituted derivative 1 with both benzyl azide and p-tolyla-
zide, were followed over time at three temperatures by 1H NMR
to allow calculations of thermodynamic data. For the unsubsti-
tuted substrate 1, 81% conversion was observed after 24 h at
25 °C, and 89% after 12 h at 40 °C (Table 1). The rate constants
are higher than for a potassium complex of a cyclic 1,4-diether
containing a but-2-yne (Fig. 1; 1.3 × 10−5 M−1 s−1), which is a
rare example of a strained alkyne based on 1,4-but-2-yne
diether structure.22 The reactivity of the dibromide 3 is similar
to that of 1, however the tetrabromo 4 was of lower reactivity,
possibly due to steric hindrance caused by the large bromine
atoms. Arylazide cycloaddition was also achieved without the
need for a catalyst, and p-tolylazide was more reactive than
o-tolylazide; again this may be due to higher steric hindrance
in the ortho-substituted azide.
The rate constants for 1, within the temperature range
examined, are similar to that reported for benzyl azide with
‘OCT’ (2.4 × 10−3 M−1 s−1), but lower than those of other
cyclooctyne reagents illustrated in Fig. 1 (DIFO; 7.6 × 10−2,
DIBO; 0.17, DIBAC; 0.31, BCN; 0.11–0.29, BARAC; 0.96
M−1 s−1). The relative reactivities are also reflected in the distorted
sp bond angles of 161/151° (DIFO2) and 153° (BARAC).30
However the reactivity of 1 and its derivatives is suﬃcient for it
to be a practical reagent for use in synthetic chemistry appli-
cations under mild, Cu-free conditions.
Whilst following the cycloaddition of 1 with benzylazide at
60 °C, we observed that cycloadduct 5a exhibited significant
peak broadening in the 1H-NMR spectrum whilst the starting
Scheme 1 Cycloadditions of strained alkynes with benzyl azide, aryl
azides and a nitrile oxide.
Fig. 4 X-ray crystallographic structure of cycloadduct 5a.
Table 1 Summary of second-order rate constants for cycloaddition
reactions
Product Temp./°C Solvent [alkyne]a/M Rate constant
5a b 25 MeCN 0.25 1.85 × 10−4 M−1 s−1
5a c 40 MeCN 0.25 7.56 × 10−4 M−1 s−1
5a d 60 MeCN 0.25 3.12 × 10−3 M−1 s−1
5a 25 CDCl3 0.10 1.28 × 10
−4 M−1 s−1
5b 25 CDCl3 0.10 1.41 × 10
−4 M−1 s−1
5c 25 CDCl3 0.10 3.64 × 10
−5 M−1 s−1
15 25 MeCN 0.25 2.50 × 10−4 M−1 s−1
7 e 25 CDCl3 0.10 3.07 × 10
−5 M−1 s−1
8 f 25 CDCl3 0.10 1.24 × 10
−4 M−1 s−1
8 40 CDCl3 0.10 5.00 × 10
−4 M−1 s−1
8 g 60 CDCl3 0.10 1.69 × 10
−3 M−1 s−1
a Alkyne : azide = 1 : 1. b 81% conv. in 24 h. c 89% conv. in 12 h.
d Benzyl azide adduct 1; ΔE‡ = 15.9 kcal mol−1, ΔH‡ = 15.2 kcal mol−1,
ΔS‡ = −24.3 cal mol−1 K. e 96% yield in 10 days. f 92% yield in 24 h. g p-
Tolylazide adduct 8: ΔE‡ = 14.6 kcal mol−1, ΔH‡ = 14.0 kcal mol−1, ΔS‡
= −29.2 cal mol−1 K.
Fig. 3 X-ray crystallographic structures of strained alkynes 2–4.
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material 1 did not. A systematic study of their variable temp-
erature 1H-NMR spectra, in d6-DMSO was completed and this
indicated that 1 did not undergo helical inversion even up to
100 °C, whereas 5a exhibited coalescence of the OCH2 peaks at
ca. 56 °C. The ΔG# required for atropisomer interconversion
was calculated to be 16.3 kcal mol−1 (ESI†). The related ali-
phatic compound 10 was independently synthesised31 and its
OCH2 peak signals were found to broaden and coalesce at
ca. 74 °C (Fig. 5; biaryl angle 55.6°, ΔG# required for atropisomer
interconversion ca. 16.7 kcal mol−1). For 5a in CD3CN solvent,
coalescence was at a similar temperature of ca. 60 °C. This con-
firms a much higher level of rigidity in 1 (and hence 2–4) com-
pared to their more flexible cycloadducts and to compound 10
(Fig. 5, ESI†). Hence the well-defined structures of the cyclic
strained alkynes oﬀers the potential for them to be used as the
basis of asymmetric ligands, and possibly as building blocks
for extended materials.
There is potential for the attachment of derivatives of 1 to
proteins and functional groups through the introduction of a
linking functional group. In order to demonstrate the potential
for this, the ester-functionalised alkyne 11 was prepared in
one step from the diphenol 12 32 in an unoptimised 50% yield
(some of the [2 + 2] and [3 + 3] products were also isolated; see
ESI† for structures). Hydrolysis of the ester to acid 13 was fol-
lowed by formation of the activated NHS ester 14 (Scheme 2).
Fig. 6 illustrates the X-ray crystallographic structures of both
11 and 13, which exhibit very similar biaryl torsion angles and
strained sp bond angles to each other and to 1–4. The reaction
of 11 with benzyl azide proceeded (Scheme 1) without a cata-
lyst, giving product 15 in 92% yield at room temperature after
a reaction period of 4 days The second order rate constant for
the cycloaddition was similar to that for 1 (Table 1), indicating
that the introduction of the ester had not significantly dimin-
ished the reactivity of the alkyne.
Reduction of 14 with DIBAL resulted in formation of
alcohol 16, which also has the potential to be converted to a
conjugation reagent. Although lower in reactivity than the
most active strained alkynes (Fig. 1), we sought to obtain pre-
liminary evidence of its potential for bioconjugation. To
obtain a proof of principle in this respect, 14 was reacted with
the small pep-tides substance P, vasopressin and bombesin,
and the protein myoglobin, the reactions being followed using
FTICR mass spectrometry (Scheme 2). The reactions of pep-
tides with the activated ester 14 in water/methanol solution
resulted in partial functionalization to give adducts 17 (see
ESI†). MS/MS studies confirmed that the lysine residue in each
peptide had been functionalised. The subsequent reaction
with an excess of benzyl azide in each case occurred with
>95% conversion to the ‘clicked’ product 18.
Solutions of myoglobin and 14 in methanol/water were pre-
pared, and after standing for one day at rt were analysed by
FTICR. Since myoglobin contains multiple lysine residues, the
protein was only partly functionalised (ca. 10%) in order to
avoid formation of a range of functionalised proteins, which
would be more diﬃcult to analyse. An excess of benzyl azide in
the same solvent was then added and after 7 days the solutions
were analysed by FTICR (Fig. 7 features an expansion of one
charged form at each stage). Significantly, the subsequent
cycloaddition reaction of the fraction of functionalised protein
had undergone >95% conversion to the ‘click’ cycloadduct.
In conclusion, we have demonstrated that strained alkynes
based on diether derivatives of 2,2′-diphenol react with azides
without the need for a metal catalyst. The strained alkyne can
be attached to a biomolecule or other group, hence demon-
strating the potential for the reagents to be used broadly in
synthetic reactions where a Cu catalyst must be avoided, and
Fig. 5 Restricted rotation of strained alkyne 1, adduct 5a and aliphatic-
ring compound 10. Also shown is the X-ray crystallographic structure
of 10.
Scheme 2 Synthesis of activated NHS ester 14 and subsequent reac-
tion with peptides and a protein.
Fig. 6 X-ray crystallographic structure of ester 11 and acid 13, and
structure of alcohol 16.
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with potential for use in bioconjugation applications.
Importantly, the strained alkynes described herein benefit
from extreme ease of synthesis, from readily available and in-
expensive starting materials.
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